Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2014, Article ID 120317, 17 pages
http://dx.doi.org/10.1155/2014/120317
Research Article

T-Cell Cytokine Gene Polymorphisms and Vitamin D Pathway Gene Polymorphisms in End-Stage Renal Disease due to Type 2 Diabetes Mellitus Nephropathy: Comparisons with Health Status and Other Main Causes of End-Stage Renal Disease

1Department of Nephrology, Transplantology and Internal Diseases, Poznań University of Medical Sciences (PUMS), 49 Przybyszewskiego Boulevard, 60-355 Poznań, Poland
2DaVita Clinic Piła Dialysis Center, Wojska Polskiego 43, 64-420 Piła, Poland
3 Student Nephrology Research Group, Department of Nephrology, Transplantology and Internal Diseases, PUMS, Przybyszewskiego 49, 60-355 Poznań, Poland
4Department of Biochemistry and Molecular Biology, PUMS, Święcickiego 6, 60-781 Poznań, Poland

Received 17 July 2014; Revised 22 September 2014; Accepted 22 September 2014; Published 22 December 2014

Academic Editor: Salwa Ibrahim

Copyright © 2014 Alicja E. Grzegorzewska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Villar, H. C. Sean, and S. P. McDonald, “Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991–2005),” Diabetes Care, vol. 30, no. 12, pp. 3070–3076, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Sattar, C. Argyropoulos, L. Weissfeld et al., “All-cause and cause-specific mortality associated with diabetes in prevalent hemodialysis patients,” BMC Nephrology, vol. 13, article 130, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Chantrel, I. Enache, M. Bouiller et al., “Abysmal prognosis of patients with type 2 diabetes entering dialysis,” Nephrology Dialysis Transplantation, vol. 14, no. 1, pp. 129–136, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Al-Thani, A. Shabana, A. Hussein et al., “Cardiovascular complications in diabetic patients undergoing regular hemodialysis: a 5-year observational study,” Angiology, 2014. View at Publisher · View at Google Scholar
  5. M. J. Sarnak and B. L. Jaber, “Mortality caused by sepsis in patients with end-stage renal disease compared with the general population,” Kidney International, vol. 58, no. 4, pp. 1758–1764, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. S.-M. Alavian and S. V. Tabatabaei, “The effect of diabetes mellitus on immunological response to hepatitis B virus vaccine in individuals with chronic kidney disease: a meta-analysis of current literature,” Vaccine, vol. 28, no. 22, pp. 3773–3777, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Zayour, M. Daouk, W. Medawar, M. Salamoun, and G. El-Hajj Fuleihan, “Predictors of bone mineral density in patients on hemodialysis,” Transplantation Proceedings, vol. 36, no. 5, pp. 1297–1301, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. D. M. Li, Y. Zhang, B. Ding et al., “The association between vitamin D deficiency and diabetic nephropathy in type 2 diabetic patients,” Zhonghua Nei Ke Za Zhi, vol. 52, no. 11, pp. 970–974, 2013 (Chinese). View at Google Scholar
  9. C.-C. Wu, H.-K. Sytwu, K.-C. Lu, and Y.-F. Lin, “Role of T cells in type 2 diabetic nephropathy,” Experimental Diabetes Research, vol. 2011, Article ID 514738, 9 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Tian, C. Wang, Z. Ye, X. Xiao, A. Kijlstra, and P. Yang, “Effect of 1,25-Dihydroxyvitamin D3 on Th17 and Th1 response in patients with Behçet's disease,” Investigative Ophthalmology and Visual Science, vol. 53, no. 10, pp. 6434–6441, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Stachowski, “Hepatitis C virus infection in renal diseases: state of knowledge, therapeutic problems and perspectives,” Polski Merkuriusz Lekarski, vol. 8, no. 46, pp. 303–306, 2000 (Polish). View at Google Scholar · View at Scopus
  12. B. D. Livingston, J. Alexander, C. Crimi et al., “Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans,” Journal of Immunology, vol. 162, no. 5, pp. 3088–3095, 1999. View at Google Scholar · View at Scopus
  13. J. Zhang, G. Hua, X. Zhang, R. Tong, X. Du, and Z. Li, “Regulatory T cells/T-helper cell 17 functional imbalance in uraemic patients on maintenance haemodialysis: a pivotal link between microinflammation and adverse cardiovascular events,” Nephrology, vol. 15, no. 1, pp. 33–41, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Borella, G. Nesher, E. Israeli, and Y. Shoenfeld, “Vitamin D: a new anti-infective agent?” Annals of the New York Academy of Sciences, vol. 1317, no. 1, pp. 76–83, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Zitt, H. Sprenger-Mähr, F. Knoll, U. Neyer, and K. Lhotta, “Vitamin D deficiency is associated with poor response to active hepatitis B immunisation in patients with chronic kidney disease,” Vaccine, vol. 30, no. 5, pp. 931–935, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Shoji and Y. Nishizawa, “Vitamin D and survival of hemodialysis patients,” Clinical calcium, vol. 14, no. 9, pp. 64–68, 2004 (Japanese). View at Google Scholar · View at Scopus
  17. L. Steingrimsdottir, O. Gunnarsson, O. S. Indridason, L. Franzson, and G. Sigurdsson, “Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake,” The Journal of the American Medical Association, vol. 294, no. 18, pp. 2336–2341, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Pacifici, “Role of T cells in the modulation of PTH action: physiological and clinical significance,” Endocrine, vol. 44, no. 3, pp. 576–582, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Zhang, J. Wang, B. Yi et al., “BsmI polymorphisms in vitamin D receptor gene are associated with diabetic nephropathy in type 2 diabetes in the Han Chinese population,” Gene, vol. 495, no. 2, pp. 183–188, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Mtiraoui, I. Ezzidi, M. Kacem et al., “Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients,” Diabetes/Metabolism Research and Reviews, vol. 25, no. 1, pp. 57–63, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Ezzidi, N. Mtiraoui, M. Kacem et al., “Interleukin-10-592C/A, -819C/T and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients,” Clinical Endocrinology, vol. 70, no. 3, pp. 401–407, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Karadeniz, M. Erdogan, A. Berdeli, and C. Yilmaz, “Association of interleukin-6 -174 G>C promoter polymorphism with increased risk of type 2 diabetes mellitus patients with diabetic nephropathy in Turkey,” Genetic Testing and Molecular Biomarkers, vol. 18, no. 1, pp. 62–65, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Murea, T. C. Register, J. Divers et al., “Relationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart Study,” BMC Nephrology, vol. 13, no. 1, article 148, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. A. E. Grzegorzewska, D. Pajzderski, A. Sowińska, and P. P. Jagodziński, “Polymporphism of monocyte chemoattractant protein 1 (MCP1-2518 A/G) and responsiveness to hepatitis B vaccination in hemodialysis patients,” Polskie Archiwum Medycyny Wewnetrznej, vol. 124, no. 1-2, pp. 10–18, 2014. View at Google Scholar · View at Scopus
  25. A. E. Grzegorzewska, D. Pajzderski, A. Sowińska, and P. P. Jagodziński, “Monocyte chemoattractant protein-1 gene (MCP-1-2518 A/G) polymorphism and serological markers of hepatitis B virus infection in hemodialysis patients,” Medical Science Monitor, vol. 20, pp. 1101–1116, 2014. View at Google Scholar
  26. Group KDIGOKCW, “KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease,” Kidney International Supplements, vol. 3, pp. 1–150, 2013. View at Google Scholar
  27. A. E. Grzegorzewska, P. Wobszal, and P. P. Jagodziński, “Interleukin-18 promoter polymorphism and development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients,” Kidney and Blood Pressure Research, vol. 35, no. 1, pp. 1–8, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. A. E. Grzegorzewska, P. M. Wobszal, A. Sowińska, A. Mostowska, and P. P. Jagodziński, “Association of the interleukin-12 polymorphic variants with the development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to vaccination or infection,” Molecular Biology Reports, vol. 40, no. 12, pp. 6899–6911, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. A. E. Grzegorzewska, P. M. Wobszal, A. Mostowska, and P. P. Jagodziński, “Antibodies to hepatitis B virus surface antigen and interleukin 12 and interleukin 18 gene polymorphisms in hemodialysis patients,” BMC Nephrology, vol. 13, no. 1, article 75, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. A. E. Grzegorzewska, D. Pajzderski, A. Sowińska, A. Mostowska, and P. P. Jagodziński, “IL4R and IL13 polymorphic variants and development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to HBV vaccination or infection,” Vaccine, vol. 31, no. 14, pp. 1766–1770, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. S. S. Rich, “Genetics of diabetes and its complications,” Journal of the American Society of Nephrology, vol. 17, no. 2, pp. 353–360, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. N. D. Palmer and B. I. Freedman, “Insights into the genetic architecture of diabetic nephropathy,” Current Diabetes Reports, vol. 12, no. 4, pp. 423–431, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Franceschini, N. M. Shara, H. Wang et al., “The association of genetic variants of type 2 diabetes with kidney function,” Kidney International, vol. 82, no. 2, pp. 220–225, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. N. D. Palmer, C. W. McDonough, P. J. Hicks et al., “A genome-wide association search for type 2 diabetes genes in african americans,” PLoS ONE, vol. 7, no. 1, Article ID e29202, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Davoodi-Semiromi, J. J. Yang, and J.-X. She, “IL-12p40 is associated with type 1 diabetes in Caucasian-American families,” Diabetes, vol. 51, no. 7, pp. 2334–2336, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. D. B. Mirel, A. M. Valdes, L. C. Lazzeroni, R. L. Reynolds, H. A. Erlich, and J. A. Noble, “Association of IL4R haplotypes with type 1 diabetes,” Diabetes, vol. 51, no. 11, pp. 3336–3341, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. T. L. Bugawan, D. B. Mirel, A. M. Valdes, A. Panelo, P. Pozzilli, and H. A. Erlich, “Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among filipinos,” The American Journal of Human Genetics, vol. 72, no. 6, pp. 1505–1514, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Frederiksen, E. Liu, J. Romanos et al., “Investigation of the vitamin D receptor gene (VDR) and its interaction with protein tyrosine phosphatase, non-receptor type 2 gene (PTPN2) on risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY),” The Journal of Steroid Biochemistry and Molecular Biology, vol. 133, no. 1, pp. 51–57, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Panierakis, G. Goulielmos, D. Mamoulakis, E. Petraki, E. Papavasiliou, and E. Galanakis, “Vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Crete, Greece,” Clinical Immunology, vol. 133, no. 2, pp. 276–281, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. Q. Wang, B. Xi, K. H. Reilly, M. Liu, and M. Fu, “Quantitative assessment of the associations between four polymorphisms (FokI, ApaI, BsmI, TaqI) of vitamin D receptor gene and risk of diabetes mellitus,” Molecular Biology Reports, vol. 39, no. 10, pp. 9405–9414, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. N. M. Al-Daghri, O. Al-Attas, M. S. Alokail et al., “Vitamin D receptor gene polymorphisms and HLA DRB1*04 cosegregation in Saudi type 2 diabetes patients,” Journal of Immunology, vol. 188, no. 3, pp. 1325–1332, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. F.-L. Vélayoudom-Céphise, L. Larifla, J.-P. Donnet et al., “Vitamin D deficiency, vitamin D receptor gene polymorphisms and cardiovascular risk factors in Caribbean patients with type 2 diabetes,” Diabetes & Metabolism, vol. 37, no. 6, pp. 540–545, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. D. A. F. Ferrarezi, N. Bellili-Muñoz, D. Dubois-Laforgue et al., “Allelic variations of the vitamin D receptor (VDR) gene are associated with increased risk of coronary artery disease in type 2 diabetics: the DIABHYCAR prospective study,” Diabetes and Metabolism, vol. 39, no. 3, pp. 263–270, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. T. B. Zhou, Z. P. Jiang, M. F. Huang, and N. Su, “Association of vitamin D receptor Fok1 (rs2228570), TaqI (rs731236) and ApaI (rs7975232) gene polymorphism with the risk of chronic kidney disease,” Journal of Receptors and Signal Transduction Research, vol. 5, pp. 1–5, 2014. View at Google Scholar
  45. R. D. Mittal and P. K. Manchanda, “Association of interleukin (IL)-4 intron-3 and IL-6 -174 G/C gene polymorphism with susceptibility to end-stage renal disease,” Immunogenetics, vol. 59, no. 2, pp. 159–165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. G. Morahan, E. McKinnon, J. Berry et al., “Evaluation of IL12B as a candidate type I diabetes susceptibility gene using data from the Type I Diabetes Genetics Consortium,” Genes and Immunity, vol. 10, supplement 1, pp. S64–S68, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. H. A. Erlich, K. Lohman, S. J. MacK et al., “Association analysis of SNPs in the IL4R locus with type i diabetes,” Genes and Immunity, vol. 10, supplement 1, pp. S33–S41, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. R. Jorde, H. Schirmer, T. Wilsgaard et al., “Polymorphisms related to the serum 25-Hydroxyvitamin D level and risk of Myocardial infarction, diabetes, cancer and mortality. The Tromsø study,” PLoS ONE, vol. 7, no. 5, Article ID e37295, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Bid, R. Konwar, C. Aggarwal et al., “Vitamin D receptor (FokI, BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus: a North Indian study,” Indian Journal of Medical Sciences, vol. 63, no. 5, pp. 187–194, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. M. C. Lemos, A. Fagulha, E. Coutinho et al., “Lack of association of vitamin D receptor gene polymorphisms with susceptibility to type 1 diabetes mellitus in the Portuguese population,” Human Immunology, vol. 69, no. 2, pp. 134–138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. T. B. Zhou, Z. P. Jiang, and M. F. Huang, “Association of vitamin D receptor BsmI ( rs1544410 ) gene polymorphism with the chronic kidney disease susceptibility,” Journal of Receptors and Signal Transduction Research, 2014. View at Publisher · View at Google Scholar
  52. E. Sánchez, R. J. Palomino-Morales, N. Ortego-Centeno et al., “Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus,” Human Molecular Genetics, vol. 18, no. 19, pp. 3739–3748, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. I. P. Kudriashova, T. P. Ospel'nikova, and F. I. Ershov, “Cycloferon administration in chronic pyelonephritis: changes in interferon status,” Terapevticheskiĭ Arkhiv, vol. 83, no. 6, pp. 33–35, 2011 (Russian). View at Google Scholar
  54. C.-C. Wu, J.-S. Chen, K.-C. Lu et al., “Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy,” Clinica Chimica Acta, vol. 411, no. 9-10, pp. 700–704, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. N. Israni, R. Goswami, A. Kumar, and R. Rani, “Interaction of Vitamin D receptor with HLA DRB1*0301 in Type 1 diabetes patients from North India,” PLoS ONE, vol. 4, no. 12, Article ID e8023, 2009. View at Publisher · View at Google Scholar · View at Scopus